News | July 23, 2013

GE Healthcare Announces CE Marking for Its Breast Tomosynthesis Solution, SenoClaire

Powered by ASiRDBT

GE Healthcare SenoClaire Mammography CE mark

July 23, 2013 — GE Healthcare, hailed a new era for breast imaging today as it announced CE marking for SenoClaire, GE’s new generation of breast tomosynthesis solution designed with a three-dimensional imaging technology. Powered by ASiRDBT, SenoClaire technology uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from images.

“Our goal was to pioneer an upgrade solution for both our digital mammography platforms, Senographe Essential and Senographe Care, providing flexibility for customers to enhance their clinical offering for their clinic and patient workflow,” said Prahlad Singh, general manager, Women’s Health, GE Healthcare — Detection and Guidance Solutions (DGS).

More precision, More confidence, Less dose: SenoClaire2

With GE’s SenoClaire, powered by ASiRDBT a single MLO view provides clinical non-inferiority compared to a two-view digital mammography exam — at half the dose and with just one compression. Subsequently, this solution has the potential to replace digital mammography exams in screening to help radiologists detect breast cancer.

In addition, SenoClaire will help deliver superior sensitivity for architectural distortions and masses, help improve specificity of lesion margin visibility and ultimately, help radiologists reduce recall rates through better characterization of findings. Finally, its images are compatible with major picture archive and communication system (PACS), so that radiologists can integrate them easily into their environment and get the most from their investment.

First shipments have started in Europe, Middle East, Australia and Latin America with a solid flow of customer sites placing orders.

SenoClaire is not FDA approved. SenoClaire may not be available in all regions.

For more information: www3.gehealthcare.com

Related Content

California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Computer Error Leads to 450,000 Missed U.K. Breast Screening Invites
News | Mammography | May 02, 2018
Since 2009, approximately 450,000 women around age 70 in the United Kingdom did not receive final breast screening...
Pilot Study Initiated for Blood-Based Breast Test
News | Oncology Diagnostics | May 01, 2018
Overlake Medical Center in Bellevue, Wash., announced it has enrolled 85 patients in a pilot study of a blood test to...
Computers Equal Radiologists in Assessing Breast Density and Associated Breast Cancer Risk
News | Breast Density | May 01, 2018
Automated breast density evaluation was just as accurate in predicting women’s risk of breast cancer, found and not...
Overlay Init